UnrestrictedBackground: Advances in pediatric cancer care which have improved outcomes in high-income countries have not reached the 80% of children with cancer who live in low-income countries. Efforts have been made to improve care for children with leukemia (the commonest childhood cancer) in low-income countries, but there has been virtually no focus on children with brain tumors (the second commonest childhood cancer). This study focused on Paraguay, a low-middle income country in South America. Only approximately 50% of the expected cases are diagnosed each year and of those, only 50% survive more than a few months after diagnosis. For children with central nervous system (CNS) tumors, preliminary data from two hospitals in Paraguay d...
Objective: Brain tumors are the second most common pediatric malignancy and the most common cause of...
Purpose: Pediatric CNS tumors are increasingly a priority, particularly with the WHO designation of ...
Purpose: Pediatric medulloblastoma (MB) treatment has evolved over the past few decades; however, tr...
In Paraguay, cancer is among the leading causes of death among children. We report challenges and so...
Abstract: LEARNING POINTS Multidisciplinary team management for pediatric neuro-oncology is a sustai...
Introduction Information about pediatric survivors of brain tumors in developing countries is scant....
Purpose: Pediatric neuro-oncology resources are mostly unknown in Chile. We report the human and mat...
PurposeTreatment of children with CNS tumors (CNSTs) demands a complex, interdisciplinary approach t...
Introduction: Brain tumors are the most common solid neoplasms and the second most common malignancy...
Backgraund: The prevalence and outcome of childhood cancers in developing countries is not well docu...
Background: Treatment of childhood brain tumours requires coordinated efforts by multiple specialiti...
With 90% of world children living in developing countries and a rising cancer incidence, the third w...
Background: Low- and middle-income countries sustain the majority of pediatric cancer burden, with s...
Purpose: The majority of new diagnoses of pediatric cancer are made in resource-poor countries, wher...
Pediatric cancer is becoming increasingly important in low-/middle-income countries (LMICs), due to ...
Objective: Brain tumors are the second most common pediatric malignancy and the most common cause of...
Purpose: Pediatric CNS tumors are increasingly a priority, particularly with the WHO designation of ...
Purpose: Pediatric medulloblastoma (MB) treatment has evolved over the past few decades; however, tr...
In Paraguay, cancer is among the leading causes of death among children. We report challenges and so...
Abstract: LEARNING POINTS Multidisciplinary team management for pediatric neuro-oncology is a sustai...
Introduction Information about pediatric survivors of brain tumors in developing countries is scant....
Purpose: Pediatric neuro-oncology resources are mostly unknown in Chile. We report the human and mat...
PurposeTreatment of children with CNS tumors (CNSTs) demands a complex, interdisciplinary approach t...
Introduction: Brain tumors are the most common solid neoplasms and the second most common malignancy...
Backgraund: The prevalence and outcome of childhood cancers in developing countries is not well docu...
Background: Treatment of childhood brain tumours requires coordinated efforts by multiple specialiti...
With 90% of world children living in developing countries and a rising cancer incidence, the third w...
Background: Low- and middle-income countries sustain the majority of pediatric cancer burden, with s...
Purpose: The majority of new diagnoses of pediatric cancer are made in resource-poor countries, wher...
Pediatric cancer is becoming increasingly important in low-/middle-income countries (LMICs), due to ...
Objective: Brain tumors are the second most common pediatric malignancy and the most common cause of...
Purpose: Pediatric CNS tumors are increasingly a priority, particularly with the WHO designation of ...
Purpose: Pediatric medulloblastoma (MB) treatment has evolved over the past few decades; however, tr...